DEVELOPMENT OF NEW-MOLECULAR AGENTS FOR HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Okusaka, T. [1 ]
机构：
[1] Natl Canc Ctr Hosp, Hepatobiliary & Pancreat Oncol Div, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [31] Emerging agents and regimens for hepatocellular carcinoma
    Xiao-Dong Zhu
    Hui-Chuan Sun
    Journal of Hematology & Oncology, 12
  • [32] Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features
    Wood, Laura D.
    Heaphy, Christopher M.
    Daniel, Hubert Darius-J
    Naini, Bita V.
    Lassman, Charles R.
    Arroyo, May R.
    Kamel, Ihab R.
    Cosgrove, David P.
    Boitnott, John K.
    Meeker, Alan K.
    Torbenson, Michael S.
    MODERN PATHOLOGY, 2013, 26 (12) : 1586 - 1593
  • [33] TREATMENT OUTCOMES OF RECURRENT HEPATOCELLULAR CARCINOMA AFTER HEPATECTOMY IN THE ERA OF MOLECULAR TARGETED AGENTS
    Horie, Hiroshi
    Ogiso, Satoshi
    Yoh, Tomoaki
    Koyama, Yukinori
    Nishio, Takahiro
    Fukumitsu, Ken
    Ishii, Takamichi
    Seo, Satoru
    Taura, Kojiro
    Hatano, Etsuro
    GASTROENTEROLOGY, 2022, 162 (07) : S1283 - S1284
  • [34] Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents
    Feng, Ying-Qi
    Li, Bo-An
    Feng, Fan
    Chen, Yong-Shou
    Ren, Yi-Xin
    Zhang, Heng
    Cao, Shuang
    ONCOTARGETS AND THERAPY, 2020, 13 : 7165 - 7176
  • [35] Optimal administration of molecular-targeted agents as secondary treatment for advanced hepatocellular carcinoma
    Nakano, Masahito
    Torimura, Takuji
    ANNALS OF ONCOLOGY, 2021, 32 : S269 - S269
  • [36] Chemotherapy for hepatocellular carcinoma: molecular targeted agents, hepatic arterial infusion chemotherapy or both?
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2017, 28 : 43 - 43
  • [37] Multidisciplinary Approach to the Treatment of Advanced Hepatocellular Carcinoma in the Era of New Biologic Agents
    Shindoh, Junichi
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2022, 89 (02) : 145 - 153
  • [38] Molecular Mechanisms of Hepatocellular Carcinoma
    Aravalli, Rajagopal N.
    Steer, Clifford J.
    Cressman, Erik N. K.
    HEPATOLOGY, 2008, 48 (06) : 2047 - 2063
  • [39] Molecular Pathogenesis of Hepatocellular Carcinoma
    Cornella, Helena
    Alsinet, Clara
    Villanueva, Augusto
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (05) : 821 - 825
  • [40] Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
    Farinati, Fabio
    Vitale, Alessandro
    Spolverato, Gaya
    Pawlik, Timothy M.
    Huo, Teh-la
    Lee, Yun-Hsuan
    Frigo, Anna Chiara
    Giacomin, Anna
    Giannini, Edoardo G.
    Ciccarese, Francesca
    Piscaglia, Fabio
    Rapaccini, Gian Lodovico
    Di Marco, Mariella
    Caturelli, Eugenio
    Zoli, Marco
    Borzio, Franco
    Cabibbo, Giuseppe
    Felder, Martina
    Sacco, Rodolfo
    Morisco, Filomena
    Biasini, Elisabetta
    Foschi, Francesco Giuseppe
    Gasbarrini, Antonio
    Baroni, Gianluca Svegliati
    Virdone, Roberto
    Masotto, Alberto
    Trevisani, Franco
    Cillo, Umberto
    PLOS MEDICINE, 2016, 13 (04)
12345